680 related articles for article (PubMed ID: 8039813)
1. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
Kramnik I; Radzioch D; Skamene E
Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene.
Wojciechowski W; DeSanctis J; Skamene E; Radzioch D
J Immunol; 1999 Sep; 163(5):2688-96. PubMed ID: 10453010
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of antigen-specific proliferation and IL-2/IL-4 production of spleen cells from mice infected with Mycobacterium bovis BCG].
Teruya K; Kawakami K; Tohyama M; Saito A
Kekkaku; 1995 Apr; 70(4):293-9. PubMed ID: 7760538
[TBL] [Abstract][Full Text] [Related]
4. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
Ladel CH; Daugelat S; Kaufmann SH
Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of the Bcg gene. I. Antigen presentation in genetically susceptible and resistant congenic mouse strains.
Denis M; Forget A; Pelletier M; Skamene E
J Immunol; 1988 Apr; 140(7):2395-400. PubMed ID: 3127465
[TBL] [Abstract][Full Text] [Related]
6. [Effect of natural resistance gene on the immune response against Mycobacterium avium complex infection].
Nakamura RM
Kekkaku; 1992 Jan; 67(1):41-6. PubMed ID: 1542207
[TBL] [Abstract][Full Text] [Related]
7. Dissection of strain difference in acquired protective immunity against Mycobacterium bovis Calmette-Guérin bacillus (BCG). Macrophages regulate the susceptibility through cytokine network and the induction of nitric oxide synthase.
Yoshida A; Koide Y; Uchijima M; Yoshida TO
J Immunol; 1995 Aug; 155(4):2057-66. PubMed ID: 7543537
[TBL] [Abstract][Full Text] [Related]
8. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
[TBL] [Abstract][Full Text] [Related]
9. Early appearing gamma/delta-bearing T cells during infection with Calmétte Guérin bacillus.
Inoue T; Yoshikai Y; Matsuzaki G; Nomoto K
J Immunol; 1991 Apr; 146(8):2754-62. PubMed ID: 1707921
[TBL] [Abstract][Full Text] [Related]
10. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG).
Stach JL; Gros P; Forget A; Skamene E
J Immunol; 1984 Feb; 132(2):888-92. PubMed ID: 6361135
[TBL] [Abstract][Full Text] [Related]
12. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
Hoft DF; Brown RM; Roodman ST
J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
[TBL] [Abstract][Full Text] [Related]
13. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
14. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
15. Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.
Moreira AL; Tsenova L; Murray PJ; Freeman S; Bergtold A; Chiriboga L; Kaplan G
Microb Pathog; 2000 Sep; 29(3):175-85. PubMed ID: 10968949
[TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG).
Gros P; Skamene E; Forget A
J Immunol; 1983 Oct; 131(4):1966-72. PubMed ID: 6311901
[TBL] [Abstract][Full Text] [Related]
17. Recombinant BCG-Rv1767 amount determines, in vivo, antigen-specific T cells location, frequency, and protective outcome.
Speranza V; Colone A; Cicconi R; Palmieri G; Giovannini D; Grassi M; Mattei M; Sali M; Delogu G; Andreola F; Colizzi V; Mariani F
Microb Pathog; 2010 May; 48(5):150-9. PubMed ID: 20219669
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the gene encoding for secretion antigen SA5K affects growth of Mycobacterium bovis bacillus Calmette-Guerin in human macrophages and in mice.
Bottai D; Esin S; Batoni G; Pardini M; Maisetta G; Donati V; Favilli F; Florio W; Campa M
Res Microbiol; 2005 Apr; 156(3):393-402. PubMed ID: 15808944
[TBL] [Abstract][Full Text] [Related]
19. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma.
Stuehr DJ; Marletta MA
J Immunol; 1987 Jul; 139(2):518-25. PubMed ID: 3110273
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the induction of persistence of major histocompatibility complex class II by hybrids of macrophages from bacillus Calmette Guerin-resistant mice.
Faris M; Zwilling BS
Eur J Immunol; 1991 Apr; 21(4):1047-52. PubMed ID: 1902174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
